PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.30 | 2.15% | 61.80 | 61.00 | 62.60 | 61.80 | 60.50 | 60.50 | 175,643 | 10:18:40 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.7 | -10.9 | -6.6 | - | 107 |
Angle (AGL) News Headlines
Angle News
| Date | Time | Source | Headline |
|---|---|---|---|
| 07/11/2019 | 13:50 | ALNC |  Angle Gets Study Results Demonstrating Use Of Parsortix In Melanoma |
| 07/11/2019 | 07:46 | ALNCF | Alliance News Flash Headline |
| 07/11/2019 | 07:01 | RNSNON | Angle PLC Cancer centre shows Parsortix use in melanoma |
| 31/10/2019 | 15:38 | ALNC | Angle Submits Positive Test Results For Parsortix System To US FDA |
| 30/10/2019 | 14:44 | UKREG | Angle PLC Result of AGM |
| 30/10/2019 | 07:00 | UKREG | Angle PLC Q-submission to FDA containing headline data |
| 08/10/2019 | 06:00 | UKREG | Angle PLC Notice of AGM |
| 04/10/2019 | 16:54 | UKREG | Angle PLC Holding(s) in Company |
| 04/10/2019 | 07:58 | ALNC | Angle Notes Queen Mary University's European Cancer Prognosis Patent |
| 04/10/2019 | 06:00 | RNSNON | Angle PLC European patent granted for megakaryocyte analysis |
1 Year Angle Chart |
Intraday Angle Chart |
